Gil-ran Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immunoregulatory protein-hybrid extracellular vesicles via self-loadable backbone cyclization for oral inflammatory bowel disease therapy.
Journal: Bioactive materials
Published: September 10, 2025
Costimulation loss enhances IL-2-driven Treg generation by PI3K-STAT3 inhibition in CNS autoimmunity.
Journal: EMBO molecular medicine
Published: May 19, 2025
Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival.
Journal: Clinical transplantation and research
Published: November 01, 2024
Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide.
Journal: Frontiers in immunology
Published: June 02, 2023
Steady-state memory-phenotype conventional CD4+ T cells exacerbate autoimmune neuroinflammation in a bystander manner via the Bhlhe40/GM-CSF axis.
Journal: Experimental & molecular medicine
Published: October 30, 2022
Unleashing cell-penetrating peptide applications for immunotherapy.
Journal: Trends in molecular medicine
Published: December 01, 2021
The Cysteine-Containing Cell-Penetrating Peptide AP Enables Efficient Macromolecule Delivery to T Cells and Controls Autoimmune Encephalomyelitis.
Journal: Pharmaceutics
Published: June 08, 2021
In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 24, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026